Select a Company
6.06 MUR 0 / 0%
As of 18-Mar-2025
Africure Pharmaceuticals Limited
Santé Pharmacie et biotechnologie6.06 MUR 0 / 0%
As of 18-Mar-2025
Cours Veille
6.06
Volume
0
Valeur Transactions
MUR 0.00
Deals
--
Actions en Circulation
9.42 mln
Capitalisation
MUR 57.07 mln
Loading Chart ...
52W RANGE
6.06 - 6.06
1W
-
1M
-
3M
-
YTD
-
1Y
-

Profile
Annonces
Actualité
Rapports
Dividendes
About the company
The principal activity of the Company is investment holding of manufacturing assets in Sub Saharan Africa, trading & procurement of pharmaceutical products. The Group is also a manufacturer and distributor of essential pharmaceutical products for human consumption (e.g. antibiotics, anti-inflammatory, anti-diabetic, pain killers, anti-viral, anti-malaria drugs). It holds manufacturing facilities in Cameroon, Cote d’Ivoire, Tanzania, Botswana, India and distribution companies in various countries. Africure’s objective is to create manufacturing capabilities in Africa and to respond to challenges faced by the African continent with regards to its overdependence on imported pharmaceutical products.
Site Web
www.africurepharma.com
info@africurepharma.com
Site Web
www.africurepharma.com
info@africurepharma.com
SYMBOL AFRP |
ISIN MU0713N00001 |
Création 2017 |
Cotation 2022 |
Téléphone - |
FAX - |
6th Floor, Tower A, 1 Cybercity, Ebene, Republic of Mauritius |
Competitors
AFRP | Further extension of deadline announcement | 25 févr. 2025 |
AFRP | Announcement extension to file | 10 févr. 2025 |
AFRP | Communique | 19 nov. 2024 |
AFRP | Communique | 14 oct. 2024 |
AFRP | SEM communique | 14 oct. 2024 |
AFRP | Notice of shareholder meeting | 1 oct. 2024 |
AFRP | Communique | 19 juin 2024 |
AFRP | Communique | 13 févr. 2024 |
AFRP | Communique | 10 nov. 2023 |
AFRP | AGM notice | 27 sept. 2023 |
AFRP | Communique | 14 févr. 2023 |
Analyse & Recherche
Rapports Annuels & Financiers
Annual Report | 2023 |
Annual Report | 2022 |
Annual Report | 2020 |
Annual Report | 2019 |
Annual Report | 2018 |